Cure Today10d
Ziftomenib Granted Breakthrough Therapy Designation by FDA in R/R AML
The investigational drug ziftomenib is currently being evaluated for patients with relapsed/refractory NPM1-mutant acute ...
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Ziftomenib is the first investigational treatment to be granted Breakthrough Therapy Designation for NPM1-mutant AML –– Registration-directed ...
alzheimersnewstoday23h
Biomarker test to ID Alzheimer’s wins FDA breakthrough designation
Elecsys Phospho-Tau 217, a blood-based test that can distinguish Alzheimer’s from other disorders, may enable an earlier ...
Soleno Therapeutics Gets Breakthrough Therapy Designation for Diazoxide Choline
By Chris Wack Soleno Therapeutics said that the Food and Drug Administration has granted Breakthrough Therapy Designation for diazoxide ...
Kura Oncology Gets FDA Breakthrough Therapy Designation For Ziftomenib In R/R NPM1-Mutant AML
Kura Oncology, Inc. (KURA) on Monday announced that it has been granted FDA Breakthrough Therapy Designation for its investigational ...